documents: FDA-2020-D-2107-0007

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2020-D-2107-0007 FDA FDA-2020-D-2107 Cross Labeling Oncology Drugs in Combination RegimensGuidance for Industry Other Guidance 2020-11-20T05:00:00Z 2020 11 2021-02-18T05:00:00Z   2022-11-03T12:46:10Z   0 0 090000648496d16b

Links from other tables